Staphylococcal enterotoxin IgE sensitization in late-onset severe eosinophilic asthma in the elderly

Clinical and Experimental Allergy

Volumn 46, Issue 3, 2016, Pages 411-421

  Song, W J ^a   Sintobin, I ^b   Sohn, K H ^a   Kang, M G ^a   Park, H K ^a,c   Jo, E J ^c   Lee, S E ^c   Yang, M S ^a,d   Kim, S H ^a,e,h   Kwon, Y E ^f   Kim, T B ^g   Park, H W ^a   Chang, Y S ^a,e   Lee, B J ⁱ   Jee, Y K ^j   Choi, B W ^k   Bachert, C ^b   Cho, S H ^a  

^a Seoul National University College of Medicine   (South Korea)

^b GHENT UNIVERSITY   (Belgium)

^c Pusan National University School of Medicine   (South Korea)

^d Seoul National University Boramae Hospital   (South Korea)

^e Seoul National University Bundang Hospital   (South Korea)

^f Chosun University College of Medicine   (South Korea)

^g University of Ulsan College of Medicine   (South Korea)

^h Hanyang University College of Medicine   (South Korea)

ⁱ Sungkyunkwan University School of Medicine   (South Korea)

^j Dankook University College of Medicine   (South Korea)

^k Chung Ang University College of Medicine   (South Korea)

more..

Author keywords

Staphylococcus aureus; Aged; Asthma; Enterotoxins; Eosinophils; Immunoglobulin E; Nasal polyps

Indexed keywords

IMMUNOGLOBULIN E; STAPHYLOCOCCUS ENTEROTOXIN; ENTEROTOXIN;

ADULT; AGED; ARTICLE; ASTHMA; CASE CONTROL STUDY; CHRONIC RHINOSINUSITIS; COHORT ANALYSIS; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EOSINOPHILIA; EOSINOPHILIC ASTHMA; FEMALE; FOLLOW UP; GERIATRIC DISORDER; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MIDDLE AGED; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; SENSITIZATION; ANTIBODY SPECIFICITY; BLOOD; EOSINOPHIL; IMMUNOLOGY; LEUKOCYTE COUNT; LUNG FUNCTION TEST; ONSET AGE; PATHOLOGY; SEVERITY OF ILLNESS INDEX; STAPHYLOCOCCUS AUREUS; VERY ELDERLY;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ANTIBODY SPECIFICITY; ASTHMA; CASE-CONTROL STUDIES; COHORT STUDIES; ENTEROTOXINS; EOSINOPHILS; FEMALE; HUMANS; IMMUNOGLOBULIN E; LEUKOCYTE COUNT; MALE; MIDDLE AGED; RESPIRATORY FUNCTION TESTS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STAPHYLOCOCCUS AUREUS;

EID: 84959048332     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12652     Document Type: Article

References (50)

1. Yáñez A, Cho SH, Soriano JB et al. Asthma in the elderly: what we know and what we have yet to know. World Allergy Organ J 2014; 7:8.
2. Christensen K, Doblhammer G, Rau R, Vaupel JW. Ageing populations: the challenges ahead. Lancet 2009; 374:1196-208.
3. Hanania NA, King MJ, Braman SS et al. Asthma in Elderly workshop p, Asthma in the elderly: current understanding and future research needs - a report of a National Institute on Aging (NIA) workshop. J Allergy Clin Immunol 2011; 128:S4-24.
4. Song WJ, Kim SH, Lim S et al. Association between obesity and asthma in the elderly population: potential roles of abdominal subcutaneous adiposity and sarcopenia. Ann Allergy Asthma Immunol 2012; 109:243-8.
5. Kim YK, Kim SH, Tak YJ et al. High prevalence of current asthma and active smoking effect among the elderly. Clin Exp Allergy 2002; 32:1706-12.
6. Bachert C, Gevaert P, Van Cauwenberge P. Staphylococcus aureus enterotoxins: a key in airway disease? Allergy 2002; 57:480-7.
7. Song WJ, Jo EJ, Lee JW et al. Staphylococcal enterotoxin specific IgE and asthma: a systematic review and meta-analysis. Asia Pac Allergy 2013; 3:120-6.
8. Semic-Jusufagic A, Bachert C, Gevaert P et al. Staphylococcus aureus sensitization and allergic disease in early childhood: population-based birth cohort study. J Allergy Clin Immunol 2007; 119:930-6.
9. Hollams EM, Hales BJ, Bachert C et al. Th2-associated immunity to bacteria in teenagers and susceptibility to asthma. Eur Respir J 2010; 36:509-16.
10. Pastacaldi C, Lewis P, Howarth P. Staphylococci and staphylococcal superantigens in asthma and rhinitis: a systematic review and meta-analysis. Allergy 2011; 66:549-55.
11. Bachert C, van Steen K, Zhang N et al. Specific IgE against Staphylococcus aureus enterotoxins: an independent risk factor for asthma. J Allergy Clin Immunol 2012; 130:376.
12. Tomassen P, Jarvis D, Newson R et al. Staphylococcus aureus enterotoxin-specific IgE is associated with asthma in the general population: a GA2LEN study. Allergy 2013; 68:1289-97.
13. Song WJ, Chang YS, Lim MK et al. Staphylococcal enterotoxin sensitization in a community-based population: a potential role in adult-onset asthma. Clin Exp Allergy 2014; 44:553-62.
14. Park HW, Kim TW, Song WJ et al. Prediction of asthma exacerbations in elderly adults: results of a 1-year prospective study. J Am Geriatr Soc 2013; 61:1631-2.
15. Bachert C, Zhang N, Holtappels G et al. Presence of IL-5 protein and IgE antibodies to staphylococcal enterotoxins in nasal polyps is associated with comorbid asthma. J Allergy Clin Immunol 2010; 126:e6.
16. Crapo RO, Casaburi R, Coates AL et al. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 2000; 161:309-29.
17. Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, Cohen N, Cervin A, Douglas R, Gevaert P, Georgalas C, Goossens H, Harvey R, Hellings P, Hopkins C, Jones N, Joos G, Kalogjera L, Kern B, Kowalski M, Price D, Riechelmann H, Schlosser R, Senior B, Thomas M, Toskala E, Voegels R, deWang Y, Wormald PJ, European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinol Suppl 2012; 3 p preceding table of contents:1-298.
18. Bernstein IL, Li JT, Bernstein DI et al. American Academy of Allergy A, Immunology, American College of Allergy A, Immunology, Allergy diagnostic testing: an updated practice parameter. Ann Allergy Asthma Immunol 2008; 100:S1-148.
19. Morris JF. Spirometry in the evaluation of pulmonary function. Western J Med 1976; 125:110-8.
20. Klion A, Weller P. Eosinophilia and eosinophil-related disorders. In: Adkinson NF Jr, Bochner BS, Burks AW, Busse WW, Holgate ST, Lemanske RF Jr, O'Hehir RE, eds. Middleton's allergy: principles and practice. Philadelphia, PA: Elsevier Inc., 2014:1205-23.
21. Kim MY, Jo EJ, Lee SE et al. Reference ranges for induced sputum eosinophil counts in Korean adult population. Asia Pac Allergy 2014; 4:149-55.
22. Spanevello A, Confalonieri M, Sulotto F et al. Induced sputum cellularity. Reference values and distribution in normal volunteers. Am J Respir Crit Care Med 2000; 162:1172-4.
23. Bateman E, Hurd S, Barnes P et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008; 31:143-78.
24. Halm EA, Mora P, Leventhal H. No symptoms, no asthma: the acute episodic disease belief is associated with poor self-management among inner-city adults with persistent asthma. Chest 2006; 129:573-80.
25. Reddel HK, Taylor DR, Bateman ED et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med 2009; 180:59-99.
26. Chung KF, Wenzel SE, Brozek JL et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J 2014; 43:343-73.
27. Lee HY, Stretton TB. Asthma in the elderly. Br Med J 1972; 4:93-5.
28. Kowalski M, Cieślak M, Pérez-Novo C, Makowska J, Bachert C. Clinical and immunological determinants of severe/refractory asthma (SRA): association with Staphylococcal superantigen-specific IgE antibodies. Allergy 2011; 66: 32-8.
29. Haldar P, Pavord ID, Shaw DE et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 2008; 178: 218-24.
30. Amelink M, de Groot JC, de Nijs SB et al. Severe adult-onset asthma: a distinct phenotype. J Allergy Clin Immunol 2013; 132:336-41.
31. van Veen IH, ten Brinke A, Gauw SA, Sterk PJ, Rabe KF, Bel EH. Consistency of sputum eosinophilia in difficult-to-treat asthma: a 5-year follow-up study. J Allergy Clin Immunol 2009; 124:615-17 e2.
32. Wu W, Bleecker E, Moore W et al. Unsupervised phenotyping of Severe Asthma Research Program participants using expanded lung data. J Allergy Clin Immunol 2014; 133:1280-8.
33. Minai-Fleminger Y, Gangwar RS, Migalovich-Sheikhet H et al. The CD48 receptor mediates Staphylococcus aureus human and murine eosinophil activation. Clin Exp Allergy 2014; 44:1335-46.
34. Hosoki K, Nakamura A, Nagao M et al. Staphylococcus aureus directly activates eosinophils via platelet-activating factor receptor. J Leukoc Biol 2012; 92:333-41.
35. Huvenne W, Callebaut I, Reekmans K et al. Staphylococcus aureus enterotoxin B augments granulocyte migration and survival via airway epithelial cell activation. Allergy 2010; 65:1013-20.
36. Huvenne W, Callebaut I, Plantinga M et al. Staphylococcus aureus enterotoxin B facilitates allergic sensitization in experimental asthma. Clin Exp Allergy 2010; 40:1079-90.
37. Mandron M, Aries MF, Brehm RD et al. Human dendritic cells conditioned with Staphylococcus aureus enterotoxin B promote TH2 cell polarization. J Allergy Clin Immunol 2006; 117:1141-7.
38. Zhang N, Holtappels G, Gevaert P et al. Mucosal tissue polyclonal IgE is functional in response to allergen and SEB. Allergy 2011; 66:141-8.
39. Herz U, Rückert R, Wollenhaupt K et al. Airway exposure to bacterial superantigen (SEB) induces lymphocyte-dependent airway inflammation associated with increased airway responsiveness-a model for non-allergic asthma. Eur J Immunol 1999; 29:1021-31.
40. Hauk PJ, Hamid QA, Chrousos GP, Leung DY. Induction of corticosteroid insensitivity in human PBMCs by microbial superantigens. J Allergy Clin Immunol 2000; 105:782-7.
41. Cardona ID, Goleva E, Ou LS, Leung DY. Staphylococcal enterotoxin B inhibits regulatory T cells by inducing glucocorticoid-induced TNF receptor-related protein ligand on monocytes. J Allergy Clin Immunol 2006; 117:688-95.
42. Lan F, Zhang N, Holtappels G et al. Staphyloccoccus aureus induces a Th2 response via TSLP and IL-33 release in human airway mucosa. 2015 AAAAI annual meeting (February 20-24, 2015): AAAAI 2015.
43. Jarvis D, Newson R, Lotvall J et al. Asthma in adults and its association with chronic rhinosinusitis: the GA2LEN survey in Europe. Allergy 2012; 67:91-8.
44. Choi EB, Hong SW, Kim DK et al. Decreased diversity of nasal microbiota and their secreted extracellular vesicles in patients with chronic rhinosinusitis based on a metagenomic analysis. Allergy 2014; 69:517-26.
45. Corriveau MN, Zhang N, Holtappels G, Van Roy N, Bachert C. Detection of Staphylococcus aureus in nasal tissue with peptide nucleic acid-fluorescence in situ hybridization. Am J Rhinol Allergy 2009; 23:461-5.
46. Hayes SM, Howlin R, Johnston DA et al. Intracellular residency of Staphylococcus aureus within mast cells in nasal polyps: a novel observation. J Allergy Clin Immunol 2015; 135:1648-51.
47. Liang Z, Zhang Q, Thomas CM et al. Impaired macrophage phagocytosis of bacteria in severe asthma. Respir Res 2014; 15:72.
48. Park HW, Song WJ, Kim SH et al. Classification and implementation of asthma phenotypes in elderly patients. Ann Allergy Asthma Immunol 2015; 114:18-22.
49. Akdis CA, Bachert C, Cingi C et al. Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol 2013; 131:1479-90.
50. Lund VJ, Kennedy DW. Staging for rhinosinusitis. Otolaryngol Head Neck Surg 1997; 117:S35-40.